Doribax (doripenem) is the fourth carbapenem antibiotic

December 2007

Doribax (doripenem) is the fourth carbapenem antibiotic... after Primaxin (imipenem/cilastatin), Merrem (meropenem), and Invanz (ertapenem).

Doribax will be used for complicated urinary tract, kidney, and intra-abdominal infections.

Carbapenems are broad-spectrum IV antibiotics...covering many gram-positive and gram-negative organisms and anaerobes.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

people will become victims of medical identity theft
Diabetes new labeling about the possible cardiovascular risk related to Avandia and other diabetes meds
Gastroenterology drugs surprise patients by causing esophageal pain
Men's Health possible hearing loss with the erectile dysfunction drugs (Viagra, etc)
Infectious Diseases Doribax (doripenem) is the fourth carbapenem antibiotic
Kidney Disease new formulation of Renagel called Renvela
Women's Health how to choose the right oral contraceptive
Women's Health stronger warnings to avoid mycophenolate (CellCept, Myfortic) during pregnancy
Neurology & Pain what to use for low back pain
Psychiatry psychiatric problems and serious allergic reactions with modafinil (Provigil)
Rheumatology More patients will get hydroxychloroquine (Plaquenil, etc) for systemic lupus erythematosus
Supplements A controversy is brewing over the natural sweetener, stevia
Cardiology when it's better to use an ACE inhibitor or an angiotensin receptor blocker (ARB)
Practice End of year is a good time to reflect on trustworthy drug information that is relevant to practice